AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Aker BioMarine

AGM Information Apr 2, 2025

3527_rns_2025-04-02_cb99e8d9-efb1-42f7-8440-67e578a15998.html

AGM Information

Open in Viewer

Opens in native device viewer

Aker BioMarine ASA – Notice of Annual General Meeting (Correction)

Aker BioMarine ASA – Notice of Annual General Meeting (Correction)

2 April 2025: Reference is made to the Notice of Annual General Meeting sent on 31 March 2025. The Notice of Annual General Meeting is adjusted so i) a new matter 7 regarding election of members to the nomination committee is included and ii) the proposed remuneration to the Company’s auditor is adjusted. The attached notice replaces the notice dated 31 March 2025.

The annual general meeting of Aker BioMarine ASA will be held on Tuesday 25 April 2025 at 13:00 CEST.

The meeting will be conducted as a virtual meeting only, and voting will be handled online during the meeting. Information about log-in details for the meeting is available in the notice of the general meeting. For further information regarding participation, please go to www.akerbiomarine/agm.

No pre-registration is needed for attending online, but attendees must be logged in before the meeting starts. Deadline for registration of advance votes and proxies is 24 April 2025 at 16:00 CET.

Please find attached the following documents

- Notice and Proxy forms for the Annual General Meeting 2025

- Proposed Resolutions for the Annual General Meeting 2025

- Remuneration Report 2024

- Proposal from the Nomination Committee

All documents to be processed in the meeting are available on www.akerbiomarine/agm.

For further information, please contact

Christopher Robin Vinter, VP Strategic Finance & IR

Mobile: +47 911 60 820

Email: [email protected]

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.

About Aker BioMarine Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.

Talk to a Data Expert

Have a question? We'll get back to you promptly.